| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Reference |
| Enterococcus faecalis |
- |
- |
7.81 － ? |
1603 |
| Enterococcus faecalis (ATCC 29212) |
- |
- |
7.81 － ? |
1603 |
| Enterococcus faecalis (BM4316 + van(A)) |
- |
- |
0.25 － ? |
199 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
0.25 － ? |
199 |
| Enterococcus faecalis (Periapical lesions) |
0.38 |
12 |
0.12 － >256 |
407 |
| Enterococcus faecalis (van(A)) |
0.25 |
16 |
0.25 － 16 |
476 |
| Enterococcus faecalis (van(B)) |
0.5 |
32 |
0.12 － 32 |
476 |
| Enterococcus faecalis (β-lactamase positive) |
8 |
16 |
8 － 16 |
476 |
| Enterococcus faecium |
0.12 |
16 |
0.12 － 64 |
476 |
| Enterococcus faecium (12311 + vancomycin-resistant) |
- |
- |
0.125 － ? |
286 |
| Enterococcus faecium (12366 + vancomycin-resistant) |
- |
- |
0.25 － ? |
286 |
| Enterococcus faecium (clinical isolate + vancomycin-resistant) |
8 |
32 |
≤0.06 － 64 |
477 |
| Enterococcus faecium (HB217 + van(B)) |
- |
- |
1 － ? |
199 |
| Enterococcus faecium (preclinical isolate + vancomycin-resistant) |
0.12 |
32 |
0.12 － 64 |
477 |
| Enterococcus faecium (Quinupristin/Dalfopristin-resistant) |
>0.5 |
>4 |
≤0.5 － >4 |
483 |
| Enterococcus faecium (van(A)) |
0.12 |
16 |
0.12 － 32 |
476 |
| Enterococcus faecium (van(B)) |
8 |
32 |
0.12 － 32 |
476 |
| Enterococcus faecium (van(D)) |
- |
- |
0.12 － 4 |
476 |
| Enterococcus faecium (vancomycin-resistant) |
0.12 |
16 |
0.06 － 16 |
55 |
| Enterococcus faecium (vancomycin-susceptible) |
0.12 |
16 |
0.06 － >32 |
55 |
| Enterococcus gallinarum |
0.25 |
16 |
0.12 － 16 |
476 |
| Enterococcus raffinosus |
0.25 |
16 |
0.12 － 16 |
476 |
| Enterococcus spp. (vancomycin-resistant) |
>4 |
>4 |
? － ? |
39 |
| Enterococcus spp. (vancomycin-susceptible) |
>4 |
>4 |
? － ? |
39 |
| Erysipelothrix rhusiopathiae |
0.5 |
0.5 |
0.5 － ? |
488 |
| Escherichia coli |
1 |
8 |
0.064 － >32 |
1544 |
| Escherichia coli |
2 |
32 |
0.25 － 1024 |
946 |
| Escherichia coli |
- |
1 |
? － ? |
1044 |